Outset Medical (OM) Liabilities and Shareholders Equity (2019 - 2026)

Outset Medical (OM) has reported Liabilities and Shareholders Equity for 8 consecutive years, with $242.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 16.07% year-over-year to $242.4 million in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 10.8% decrease from a year earlier, with the FY2025 full-year figure at $264.5 million, down 4.1% from the prior year.
• Liabilities and Shareholders Equity was $242.4 million for Q2 2026 at Outset Medical, down from $249.5 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $431.7 million in Q1 2022 and troughed at $242.4 million in Q2 2026.
• A 5-year average of $320.6 million and a median of $310.7 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The widest YoY moves for Liabilities and Shareholders Equity: up 13.67% in 2022, down 25.18% in 2022.
• Over 5 years, Liabilities and Shareholders Equity stood at $400.1 million in 2022, then retreated by 21.57% to $313.8 million in 2023, then dropped by 12.11% to $275.8 million in 2024, then retreated by 4.1% to $264.5 million in 2025, then slipped by 8.36% to $242.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $242.4 million (Q2 2026), $249.5 million (Q1 2026), and $264.5 million (Q4 2025), per Business Quant data.